Moderna Inc. recently published the transcript for their first-quarter 2025 earnings call, held on May 1, 2025. The event was attended by key members of Moderna's management team, including CEO Stephane Bancel, President Stephen Hoge, and CFO James Mock. The call was moderated by Lavina Talukdar, Senior Vice President and Head of Investor Relations. During the conference, the management discussed Moderna's financial results and business updates for the first quarter of 2025. James Mock highlighted the company's market share, stating, "The script data through the first part of this year is really pretty similar to last year and 38% market share." Stephane Bancel emphasized the company's strategic focus, saying, "As you can see, we are really focused on executing on our strategy." The management also addressed inquiries about the flu vaccine interim data expected in Summer 2025, although specific details were not provided in the call. The full transcript can be accessed through the link below.